Sign In
to Vote &
Create Storyboards.
 
A hormone called FGF21 can reverse obesity in mice by activating a newly identified brain circuit tied to metabolism. Surprisingly, it works in the hindbrain-the same region targeted by GLP-1 drugs like Ozempic and Wegovy-but through a completely different mechanism. Instead of suppressing appetite, FGF21 ramps up the bodys energy burning. This insight could pave the way for more targeted weight-loss and liver disease treatments.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard